Posted by Claus Andersen, Partner
There has been much publicity about the various support measures and schemes put in place to support businesses affected by COVID-19 such as the Coronavirus Business Interruption Loan Scheme (CBILS) and the Job Retention Scheme. One of the less publicised measures is specific support for UK businesses trading abroad.
Posted by Claus Andersen, Partner
In light of the Coronavirus outbreak the Medicines and Healthcare products Regulatory Authority (MHRA), which is the authority which supervises the Medical Device and Pharmaceutical sector, has recently released a series of guidance notes about how the MHRA will deal with certain aspects of the Life Sciences sector during the COVID-19 outbreak.
Posted by Claus Andersen, Partner
When you cover Brexit, like I do, you cannot help feeling a bit like the proverbial ‘boy who cried wolf’. Over the past three and a half years, all of us dealing with Brexit in blogs, comments and seminars have said on numerous occasions that “Brexit was coming” – only for it to be delayed, over and over again. However, this time the wolf is real: Brexit is actually coming.
Posted by Claus Andersen, Partner
On Thursday 14 November I attended a great event at the offices of Deutsche Bank hosted and organised by the Swedish Chamber of Commerce in London.
Posted by Claus Andersen, Partner
Posted by Claus Andersen, Partner
Recent weeks have in the news been dominated by Brexit, the withdrawal agreement, the suspension of Parliament and in the end the Queen’s speech.
Posted by Claus Andersen, Partner
The Brexit task group at UK law firm Royds Withy King is advising business owners of the steps they need to take to make sure they can continue to trade with the EU in the event of a no deal Brexit.
Posted by Claus Andersen, Partner
Your commercial contracts may be vulnerable to political changes. Have you considered if you need to renegotiate? Or engage with your supply chain? Or add extra protection for your IP?
Posted by Claus Andersen, Partner
Long standing client from charity sector with a patient data base, came to us with the need for legal advice. It had been approached by a European Pharmaceutical, (EP). EP wanted to have access to our client’s database in order …
Posted by Claus Andersen, Partner
“The life sciences industry represents one of the dominant economic sectors in the UK.
It brings significant jobs and growth to virtually every region. To retain the UK’s competitive edge in this sector, there is a requirement for sustained effort over a longer period of time”.
Professor Sir John Bell, Regius Professor of Medicine, University of Oxford and Chairman, Office for the Strategic Coordination of Health Research.
Posted by Claus Andersen, Partner
Posted by Claus Andersen, Partner
On 11th October 2018 Thomas Bjørn and Claus Andersen attended the annual meeting of the Medicon Valley Alliance.
